HRT Financial’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,800
Closed -$6.13M 4325
2025
Q4
$6.13M Buy
+35,800
New +$5.57M 0.02% 685
2025
Q3
Sell
-9,800
Closed -$953K 3323
2025
Q2
$953K Sell
9,800
-12,000
-55% -$952K ﹤0.01% 1291
2025
Q1
$1.58M Buy
+21,800
New +$1.72M 0.01% 912
2024
Q3
Sell
-10,000
Closed -$1.06M 2827
2024
Q2
$1.06M Buy
+10,000
New +$959K 0.01% 987
2023
Q2
Sell
-14,000
Closed -$742K 2912
2023
Q1
$742K Buy
+14,000
New +$687K 0.01% 1115
2021
Q3
Sell
-29,000
Closed -$1.89M 3553
2021
Q2
$1.89M Buy
+29,000
New +$1.83M 0.02% 655
2020
Q3
Sell
-19,000
Closed -$614K 2163
2020
Q2
$614K Buy
+19,000
New +$518K 0.02% 713

Other funds holding LRCX

HRT Financial's LRCX Position: Q1 2026 in Review

HRT Financial increased its Lam Research (LRCX) stake by 55% in Q1 2026, buying an estimated $67.9M and bringing the position to 858,216 shares worth $183M. The position accounts for 0.46% of the portfolio, ranked #24.

HRT Financial first reported a position in LRCX in Q1 2018 and has held it in 21 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • HRT Financial held 858,216 shares of Lam Research worth $183M as of Q1 2026.
  • HRT Financial bought 303,605 Lam Research shares in Q1 2026, an estimated $67.9M.
  • Lam Research made up 0.46% of HRT Financial's portfolio in Q1 2026, its #24 holding.
  • HRT Financial first reported a position in Lam Research in Q1 2018 and has held it in 21 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.